5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant plus chemoradiotherapy (CRT) vs placebo plus CRT in a randomized, phase II study

被引：9
|
作者：
Bourhis, J. [1 ]
Le Tourneau, C. [2 ]
Calderon, B. [3 ]
Martin, L. [4 ]
Sire, C. [5 ]
Pointreau, Y. [6 ]
Ramee, J-F. [7 ]
Coutte, A. [8 ]
Boisselier, P. [9 ]
Kaminsky-Forrett, M-C. [10 ]
Delord, J-P. [11 ]
Clatot, F. [12 ]
Sun, X. [13 ,14 ]
Villa, J. [15 ]
Magne, N. [16 ]
Elicin, O. [17 ]
Damstrup, L. [18 ]
Gollmer, K. [19 ]
Crompton, P. [20 ]
Tao, Y. [21 ]
机构：
[1] CHU Vaudois, Dept Radiat Oncol, Lausanne, Switzerland
[2] Inst Curie, Dept Drug Dev & Innovat, Paris, France
[3] Avignon Provence Canc Inst, Oncol Radiotherapy, Avignon, France
[4] William Conqueror Ctr, Radiotherapie, Le Havre, France
[5] South Brittany Hosp Grp, Hop Scorff, Radiotherapie, Lorient, France
[6] Ctr Jean Bernard, Inst Inter Reg Cancerol, Oncol, Radiotherapy, Le Mans, France
[7] CHD Vendee, Onco Hematol Dept, La Roche sur Yon, France
[8] CHU Amiens Picardie, Oncol Radiotherapy Dept, Amiens, France
[9] Montpellier Canc Inst, Oncol Radiotherapie, Montpellier, France
[10] Canc Inst Lorraine Alexis Vautrin, Oncol Med, Nancy, France
[11] IUCT Oncopole, Med Oncol Dept, Inst Claudius Regaud, Toulouse, France
[12] Ctr Henri Becquerel, Serv Oncol Med, Rouen, France
[13] Nord Franche Comte Montbeliard, Dept Radiat Oncol, Montbeliard, France
[14] CHRU Besancon, Dept Radiat Oncol, Montbeliard, France
[15] CHU Grenoble, Pole Cancerol, Dept Radiat, Grenoble, France
[16] Inst Cancerol Lucien Neuwirth, Radiotherapie, St Etienne, France
[17] Univ Bern, Univ Hosp Bern, Inselspital, Dept Radiat Oncol, Bern, Switzerland
[18] Debiopharm Int SA, Clin Res Dept, Lausanne, Switzerland
[19] Debiopharm Int SA, Clin Dev, Lausanne, Switzerland
[20] Debiopharm Int SA, Lausanne, Switzerland
[21] Inst Gustave Roussy, Dept Radiat Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.08.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA33
引用
收藏
页码：S1400 / S1400
页数：1
相关论文
共 50 条
  • [41] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [42] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [43] A phase 1, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    El-Hariry, I.
    Harrington, K.
    Bourhis, J.
    Holford, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S30 - S30
  • [44] A phase II study of vinorelbine GIRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Guillem, V
    Muñoz, MA
    Yaya, R
    Soriano, V
    Climent, MA
    Gaspar, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S176 - S176
  • [45] The role of PET for predicting nodal response in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) treated with chemoradiotherapy (CRT): Results of a prospective multicenter trial.
    Schmitz, Sandra
    Van Maanen, Aline
    Rousseaux, Laura
    Andry, Guy
    Temam, Stephane
    Dequanter, Didier
    Vergez, Sebastien
    Lallemant, Benjamin
    De Raucourt, Dominique
    Jegoux, Franck
    Hanin, Francois-Xavier
    Gregoire, Vincent
    Hamoir, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Phase I Trial of Albumin-bound Paclitaxel (A), Cisplatin (P) and 5-Fluorouracil (F) as Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy (CRT) With Carboplatin (Cb) in Patients (pts) With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Diaz-Padilla, I.
    Waldron, J.
    Hope, A.
    Chen, E. X.
    Chan, K.
    Kim, J.
    O'Sullivan, B.
    Razak, A. R. Abdul
    Chin, S. F.
    Siu, L. L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S547 - S547
  • [47] Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
    Machiels, Jean-Pascal
    Tao, Yungan
    Licitra, Lisa
    Burtness, Barbara
    Tahara, Makoto
    Rischin, Danny
    Alves, Gustavo
    Lima, Iane Pinto Figueiredo
    Hughes, Brett G. M.
    Pointreau, Yoann
    Aksoy, Sercan
    Laban, Simon
    Greil, Richard
    Burian, Martin
    Hetnal, Marcin
    Delord, Jean-Pierre
    Mesia, Ricard
    Taberna, Miren
    Waldron, John N.
    Simon, Christian
    Gregoire, Vincent
    Harrington, Kevin J.
    Swaby, Ramona F.
    Zhang, Yayan
    Gumuscu, Burak
    Bidadi, Behzad
    Siu, Lillian L.
    LANCET ONCOLOGY, 2024, 25 (05): : 572 - 587
  • [48] Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial
    Tao, Yungan
    Sun, Xu-Shan
    Pointreau, Yoann
    Le Tourneau, Christophe
    Sire, Christian
    Kaminsky, Marie-Christine
    Coutte, Alexandre
    Alfonsi, Marc
    Calderon, Benoit
    Boisselier, Pierre
    Martin, Laurent
    Miroir, Jessica
    Ramee, Jean-Francois
    Delord, Jean-Pierre
    Clatot, Florian
    Rolland, Frederic
    Villa, Julie
    Magne, Nicolas
    Elicin, Olgun
    Gherga, Elisabeta
    Nguyen, France
    Lafond, Cedrik
    Bera, Guillaume
    Calugaru, Valentin
    Geoffrois, Lionnel
    Chauffert, Bruno
    Damstrup, Lars
    Crompton, Philippa
    Ennaji, Abdallah
    Gollmer, Kathrin
    Nauwelaerts, Heidi
    Bourhis, Jean
    EUROPEAN JOURNAL OF CANCER, 2023, 183 : 24 - 37
  • [49] A phase I, open-label study (EGF100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Bourhis, Jean
    Harrington, Kevin
    Rosine, D.
    Nutting, Christopher M.
    Lusinchi, Antoine
    Gardiner, Sophie J.
    Theodosiou, Aspasia M.
    El-Hariry, Iman A.
    ANNALS OF ONCOLOGY, 2006, 17 : 180 - 180
  • [50] A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN)
    Karapanagiotou, E. M.
    Chester, J. D.
    Pandha, H. S.
    Gill, G. M.
    Coffey, M. C.
    Mettinger, K.
    Harrington, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345